Telesis Bio, Inc. (TBIO)

USD 0.49

(-7.55%)

Operating Expenses Summary of Telesis Bio, Inc.

Telesis Bio, Inc.'s latest annual operating expenses in 2023 was 63.48 Million USD , down -22.68% from previous year.
Telesis Bio, Inc.'s latest quarterly operating expenses in 2024 Q1 was 8.79 Million USD , down -13.7% from previous quarter.
Telesis Bio, Inc. reported a annual operating expenses of 62.08 Million USD in annual operating expenses 2022, up 56.48% from previous year.
Telesis Bio, Inc. reported a annual operating expenses of 39.67 Million USD in annual operating expenses 2021, up 98.5% from previous year.
Telesis Bio, Inc. reported a quarterly operating expenses of 8.86 Million USD for 2024 Q2, up 21.61% from previous quarter.
Telesis Bio, Inc. reported a quarterly operating expenses of 13.11 Million USD for 2023 Q3, down -3.96% from previous quarter.

Annual Operating Expenses Chart of Telesis Bio, Inc. (2023 - 2016)

Historical Annual Operating Expenses of Telesis Bio, Inc. (2023 - 2016)

Year	Operating Expenses	Operating Expenses Growth
2023	63.48 Million USD	-22.68%
2022	62.08 Million USD	56.48%
2021	39.67 Million USD	98.5%
2020	19.98 Million USD	591.08%
2019	2.89 Million USD	-96.41%
2018	80.63 Million USD	31.46%
2017	61.33 Million USD	128.84%
2016	26.8 Million USD	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q1	8.79 Million USD	-13.7%
2024 Q2	8.86 Million USD	21.61%
2023 Q3	13.11 Million USD	-3.96%
2023 Q2	13.65 Million USD	-5.68%
2023 Q4	10.18 Million USD	-22.34%
2023 FY	47.99 Million USD	-22.68%
2023 Q1	14.48 Million USD	1.06%
2022 FY	62.08 Million USD	56.48%
2022 Q1	15.64 Million USD	20.51%
2022 Q4	14.33 Million USD	-3.89%
2022 Q3	14.91 Million USD	-13.31%
2022 Q2	17.19 Million USD	9.96%
2021 FY	39.67 Million USD	98.5%
2021 Q1	7.56 Million USD	24.26%
2021 Q2	8.52 Million USD	12.68%
2021 Q4	12.97 Million USD	22.41%
2021 Q3	10.6 Million USD	24.38%
2020 Q1	4.4 Million USD	-86.38%
2020 Q2	4.29 Million USD	-2.61%
2020 Q3	5.19 Million USD	21.03%
2020 Q4	6.08 Million USD	17.19%
2020 FY	19.98 Million USD	591.08%
2019 Q4	32.37 Million USD	33.91%
2019 FY	2.89 Million USD	-96.41%
2019 Q3	24.17 Million USD	-1.22%
2019 Q2	24.47 Million USD	2.08%
2019 Q1	23.97 Million USD	4.02%
2018 Q1	17.48 Million USD	0.44%
2018 Q2	21.21 Million USD	21.33%
2018 Q3	18.89 Million USD	-10.94%
2018 Q4	23.05 Million USD	22.02%
2018 FY	80.63 Million USD	31.46%
2017 FY	61.33 Million USD	128.84%
2017 Q1	12.59 Million USD	0.0%
2017 Q2	16.63 Million USD	32.05%
2017 Q3	14.7 Million USD	-11.59%
2017 Q4	17.4 Million USD	18.36%
2016 FY	26.8 Million USD	0.0%

Peer Operating Expenses Comparison of Telesis Bio, Inc.

Name	Operating Expenses	Operating Expenses Difference
Acutus Medical, Inc.	11.22 Million USD	-465.654%
Biotricity, Inc.	17.18 Million USD	-269.454%
Cell MedX Corp.	313.43 Thousand USD	-20156.198%
Dynatronics Corporation	9.9 Million USD	-540.784%
Nemaura Medical Inc.	7.13 Million USD	-789.351%
PetVivo Holdings, Inc.	11.36 Million USD	-458.839%
RetinalGenix Technologies Inc.	2.08 Million USD	-2942.046%
Sonendo, Inc.	68.46 Million USD	7.268%
Talis Biomedical Corporation	67.18 Million USD	5.503%
Viveve Medical, Inc.	22.17 Million USD	-186.335%